Trial Profile
A phase I randomized, open-label, 4-period, 4-sequence, crossover study investigating pharmacokinetic profile of multiple doses of co crystal of Tramadol-Celecoxib in healthy male and female volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Sep 2017
Price :
$35
*
At a glance
- Drugs Celecoxib/tramadol (Primary)
- Indications Acute pain; Dental pain; Pain
- Focus Pharmacokinetics
- 09 Sep 2017 Results published in the British Journal of Clinical Pharmacology
- 21 Nov 2016 New trial record
- 30 Sep 2016 Results presented at the 16th World Congress on Pain